Stryker (NYSE:SYK) Given Overweight Rating at Piper Sandler

Piper Sandler restated their overweight rating on shares of Stryker (NYSE:SYK – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a $380.00 target price on the medical technology company’s stock. SYK has been the topic of a number of other reports. Needham & Company LLC boosted […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Lowers Esperion Therapeutics (NASDAQ:ESPR) to Hold
Next post StockNews.com Lowers Trex (NYSE:TREX) to Sell